Product Image

Omega Memory with Curcumin

Nordic Naturals
4.7
★ ★ ★ ★ ★
(791 ratings)
Huperzine 25 mcg
Curcumin 400 mg
Omega-3 1000 mg
Product Image
Score73
A coherent memory formula with enhanced-delivery curcumin and a useful total omega-3 amount. Huperzine interactions and missing EPA/DHA details require careful use.
How scoring works
Quantity:60 Softgel(s) • (30 servings)
Goals:
Joint Health
Skin Health

Score 73

A coherent memory formula with enhanced-delivery curcumin and a useful total omega-3 amount. Huperzine interactions and missing EPA/DHA details require careful use.
How scoring works
$36.94($1.23 per serving)
Amazon
$ 49.26
Daily Vita
$ 49.26
Pure Formulas
$ 49.26
Vitacost
$ 36.94
iHerb
$ 49.26
Walmart
$ 49.26
Report prices

Analysis

The two-softgel serving combines 400 mg Longvida curcumin, 1,000 mg total omega-3, 100 mg phosphatidylcholine, and 25 mcg huperzine A. Longvida improves confidence in curcumin delivery, while huperzine and phosphatidylcholine provide a clear memory-oriented rationale.

Curcumin and omega-3 fats add useful support for inflammatory balance and joint comfort, but the formula remains designed primarily for cognition. Huperzine and phosphatidylcholine add little direct value for metabolism or skin, so those goals are secondary.

The EPA and DHA split, omega-3 source and form, active curcuminoid yield, and huperzia standardization are not stated. Huperzine A also requires more care than a basic nutrient because it can increase cholinergic effects and slow heart rate.

Who is it for
  • Adults seeking a memory-focused multi-ingredient softgel
  • Users specifically looking for low-dose huperzine A
  • People who want curcumin alongside cognitive ingredients
Best for
  • Memory-support routines
  • Curcumin with omega-3 supplementation
  • Users who understand huperzine precautions

Pros

  • Uses enhanced-delivery Longvida curcumin
  • Provides a meaningful total omega-3 amount
  • Includes a clearly stated huperzine A dose
  • Phosphatidylcholine complements the cognitive design

Cons

  • EPA and DHA are not separated
  • Omega-3 source and form are missing
  • Curcuminoid yield is not disclosed
  • Huperzia standardization is absent
  • Poor fit for metabolism goals

Warnings

  • Huperzine A can slow heart rate and may be unsuitable for people with bradycardia or conduction problems
  • Do not combine huperzine A casually with acetylcholinesterase inhibitors, anticholinergic medicines, or other strong cholinergic products
  • Huperzine A may cause nausea, sweating, vivid dreams, muscle twitching, or dizziness
  • Curcumin and omega-3 fats may add to anticoagulant or antiplatelet effects and increase bruising or bleeding risk

Nutrient quality

80 High impact

Enhanced curcumin delivery and a useful omega total provide strong core quality. Missing fatty-acid detail and a cognitive active that does not fit every configured goal create uneven balance.

Ingredient transparency

77 High impact

Every listed active has a stated amount and no proprietary blend hides the formula. Missing EPA and DHA splits, omega source, cycling guidance, non-active ingredients, and full directions leave important gaps.

Customer satisfaction

70 High impact

The supplied average is strong and supported by substantial response volume. No comment-level evidence is available to assess repeated complaints or alignment with the intended use.

Value for money

63 Moderate impact

Enhanced curcumin and useful total omega content provide meaningful formula value. High serving cost and incomplete omega disclosure limit category competitiveness.

Report analysis

Goals

Joint Health
Joint Health
Impact
High effect
A- Goal FitB+ Strength of SupportC+ CoverageD+ Formula Quality
Omega-3 · 1000 mgCurcumin · 400 mg

Longvida curcumin provides a developed absorption system with direct relevance to inflammatory joint comfort. The total omega-3 amount adds a complementary fatty-acid pathway, although separate EPA and DHA amounts are missing.

Curcumin gives the formula useful depth, while phosphatidylcholine and huperzine A are aimed at cognition rather than joint support. Huperzine A can slow heart rate or cause cholinergic effects and may interact with medicines that raise or block acetylcholine.

Study evidence
Curcumin Supportive 62 studies
Omega-3 Supportive 40 studies
Skin Health
Skin Health
Impact
Moderate effect
B- Goal FitC+ Strength of SupportC+ CoverageD Formula Quality
Omega-3 · 1000 mg

Omega-3 fats and curcumin offer barrier and antioxidant relevance, while the formula is primarily designed for cognition. Curcumin has antioxidant evidence, but the complete cognitive formula lacks direct human trials for skin outcomes.

The 1,000 mg total omega-3 amount is useful, but active EPA and DHA amounts are not separated. Huperzine A may cause nausea or slow heart rate and can interact with medicines that affect acetylcholine.

Study evidence
Omega-3 Supportive 35 studies

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Fat
1.5 Gram(s)
Cholesterol
15 mg
Longvida Optimized Curcumin extract (Curcuma longa)
 400 mg
Phosphatidylcholine
100 mg
Huperzine A (Huperzia serrata)
 25 mcg
Total Omega-3 Fatty Acids
1000 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
Huperzine (Huperzia serrata) · 25 mcg OverallScore80
A+ Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyB- Value

The softgel provides a clear 25 mcg Huperzine A amount from Huperzia serrata at the low end of the useful range. Precise delivery supports consistent use, but extract standardization and cycling guidance are missing. Its high Huperzine A cost is partly balanced by omega-3 fats, curcumin, and phosphatidylcholine.

View ingredientView products
Curcumin (Curcuma longa) · 400 mg OverallScore75
A Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyD- Value

Longvida provides a clinically developed delivery system with better absorption than a basic curcumin extract. The branded complex has a substantial listed amount, but its active yield and testing credentials are not disclosed. Huperzine A adds a separate cholinergic active that may be unsuitable with cholinergic medicines or conditions involving excess cholinergic activity.

View ingredientView products
Omega-3 · 1000 mg OverallScore24
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

The serving lists 1000 mg of total omega-3, but the EPA and DHA split is absent. Added curcumin, phosphatidylcholine, and huperzine A do not resolve the missing omega-3 form, source, testing, or active-dose value. Huperzine A may cause nausea or a slow heart rate and deserves caution with medicines that affect acetylcholine.

View ingredientView products
Loading alternative details
78 Performance

Omega Curcumin

Nordic Naturals
<p>Enhanced curcumin, omega-three fats, N-acetyl-L-cysteine, and reduced glutathione provide a coherent antioxidant alternative to the original. Omega-three details and curcuminoid yield remain incomplete, while combined curcumin and omega threes may increase bleeding tendency with relevant medicines.</p>
71 Budget

Whole Body Curcumizer

Natural Factors CurcuminRich
<p>Lower serving cost adds DHA-rich fish oil, enhanced-delivery curcumin, Boswellia, astaxanthin, and fruit polyphenols for broad inflammation support. EPA, curcuminoid yield, and several blend amounts remain missing, and it omits the original huperzine A.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effect of Losartan and Fish Oil on Plasma IL-6 and Mobility in Older Persons. The ENRGISE Pilot Randomized Clinical Trial.
    Pahor M; Anton SD; Beavers DP; Cauley JA; Fielding RA; Kritchevsky SB; Leeuwenburgh C; Lewis KH; Liu CK; Lovato LC; Lu J; Manini TM; McDermott MM; Miller ME; Newman AB; Radziszewska B; Stowe CL; Tracy RP; Walkup MP; Wu SS; Ambrosius WT · The journals of gerontology. Series A, Biological sciences and medical sciences · 2020
    Randomized trial289 participantsJoint Health forOmega-3
  2. Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial.
    Rahimnia AR; Panahi Y; Alishiri G; Sharafi M; Sahebkar A · Drug research · 2016
    Randomized trial40 participantsJoint Health forCurcumin
  3. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC; Song GG · Archives of medical research · 2013
    Meta-analysis10 studies pooledJoint Health forOmega-3
  4. The Oral Administration of Highly-Bioavailable Curcumin for One Year Has Clinical and Chondro-Protective Effects: A Randomized, Double-Blinded, Placebo-Controlled Prospective Study.
    Nakagawa Y; Mori K; Yamada S; Mukai S; Hirose A; Nakamura R · Arthroscopy, sports medicine, and rehabilitation · 2022
    Randomized trial50 participantsJoint Health forCurcumin
  5. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis.
    Zeng L; Yu G; Hao W; Yang K; Chen H · Bioscience reports · 2022
    Meta-analysis1,621 participants15 studies pooledJoint Health forCurcumin
  6. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  7. A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms.
    Mathieu S; Soubrier M; Peirs C; Monfoulet LE; Boirie Y; Tournadre A · Nutrients · 2022
    Meta-analysis1,438 participants12 studies pooledJoint Health forCurcumin
  8. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  9. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.
    Zhao J; Liang G; Zhou G; Hong K; Yang W; Liu J; Zeng L · Journal of ethnopharmacology · 2024
    Meta-analysis2,175 participants23 studies pooledJoint Health forCurcumin
  10. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  11. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
    Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H · Frontiers in immunology · 2022
    Meta-analysis2,396 participants29 studies pooledJoint Health forCurcumin
  12. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  13. Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Thanawala S; Shah R; Alluri KV; Bhupathiraju K; Prasad N; Agarwal Y · Journal of pain research · 2025
    Randomized trial139 participantsJoint Health forCurcumin
  14. Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose.
    Hill CL; March LM; Aitken D; Lester SE; Battersby R; Hynes K; Fedorova T; Proudman SM; James M; Cleland LG; Jones G · Annals of the rheumatic diseases · 2016
    Randomized trial202 participantsJoint Health forOmega-3
  15. Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.
    Henrotin Y; Malaise M; Wittoek R; de Vlam K; Brasseur JP; Luyten FP; Jiangang Q; Van den Berghe M; Uhoda R; Bentin J; De Vroey T; Erpicum L; Donneau AF; Dierckxsens Y · Arthritis research & therapy · 2020
    Randomized trial150 participantsJoint Health forCurcumin
  16. Dietary Long-Chain n-3 Fatty Acid Intake and Arthritis Risk in the Women's Health Initiative.
    Krok-Schoen JL; Brasky TM; Hunt RP; Rohan TE; Baker TA; Li W; Carbone L; Mackey RH; Snetselaar L; Lustberg MB; Neuhouser ML · Journal of the Academy of Nutrition and Dietetics · 2019
    Cohort study80,551 participantsJoint Health forOmega-3
  17. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study.
    Nakagawa Y; Mukai S; Yamada S; Matsuoka M; Tarumi E; Hashimoto T; Tamura C; Imaizumi A; Nishihira J; Nakamura T · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2015
    Randomized trial50 participantsJoint Health forCurcumin
  18. Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study).
    Giudici KV; de Souto Barreto P; Beard J; Cantet C; Araujo de Carvalho I; Rolland Y; Vellas B; MAPT DSA group · Maturitas · 2020
    Randomized trial1,445 participantsJoint Health forOmega-3
  19. The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.
    Bideshki MV; Jourabchi-Ghadim N; Radkhah N; Behzadi M; Asemani S; Jamilian P; Zarezadeh M · Phytotherapy research : PTR · 2024
    Meta-analysis11 studies pooledJoint Health forCurcumin
  20. Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial.
    Kristensen S; Schmidt EB; Schlemmer A; Rasmussen C; Johansen MB; Christensen JH · Scandinavian journal of rheumatology · 2018
    Randomized trial145 participantsJoint Health forOmega-3
  21. The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis.
    Hsiao AF; Lien YC; Tzeng IS; Liu CT; Chou SH; Horng YS · Complementary therapies in medicine · 2021
    Meta-analysis1,258 participants11 studies pooledJoint Health forCurcumin
  22. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  23. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  24. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  25. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsSkin Health forOmega-3
  26. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  27. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3